Bioxyne Ltd.

Bioxyne Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0
Market Cap
AUD12.8 M
Shares Outstanding
640.15 M
Public Float
-

Profile

Address
50 Clarence Street
Sydney New South Wales (NSW) 2000
Australia
Employees -
Website http://www.bioxyne.com
Updated 07/08/2019
Bioxyne Ltd. focuses on the development of immune health and immunotherapeutic products. It manufactures, markets, and distributes over-the-counter dietary supplement probiotic products, such as Lactobacillus Fermentum PCC. It operates through the Probiotics and Others segments.

Financials

View All
Created with Highcharts 5.0.14Bioxyne Ltd.Net Income. Fiscal year is July-June. All values AUD Thousands.1 1901 1902012012232237657651 3111 311201420152016201720180250500750100012501500
Created with Highcharts 5.0.14Bioxyne Ltd.Sales/Revenue. Fiscal year is July-June. All values AUD Thousands.2 3052 3051 4921 4921 9241 9241 7861 7861 9911 9912014201520162017201805001000150020002500

Nam-Hoat Chua
Chief Executive Officer & Director
Peter Charles Hughes-Hallett
Non-Executive Director